Drugs / SAR447971
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07629336 | May 2026 → Feb 2028 expected | hidradenitis | Sanofi | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR447971 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07629336 ↗ |
| Route | Oral | “Route of administration: Oral” NCT07629336 ↗ |